[HTML][HTML] Human serum albumin, systemic inflammation, and cirrhosis
V Arroyo, R García-Martinez, X Salvatella - Journal of hepatology, 2014 - Elsevier
Human serum albumin (HSA) is one of the most frequent treatments in patients with
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …
[PDF][PDF] Human serum albumin, systemic inflammation, and cirrhosis
V Arroyo, R García-Martinez, X Salvatella - Journal of Hepatology, 2014 - core.ac.uk
Human serum albumin (HSA) is one of the most frequent treatments in patients with
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …
[引用][C] Human serum albumin, systemic inflammation, and cirrhosis
V Arroyo, R García-Martinez, X Salvatella - Journal of Hepatology, 2014 - cir.nii.ac.jp
[PDF][PDF] Human serum albumin, systemic inflammation, and cirrhosis
V Arroyo, R García-Martinez, X Salvatella - 2014 - researchgate.net
Human serum albumin (HSA) is one of the most frequent treatments in patients with
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …
Human serum albumin, systemic inflammation, and cirrhosis
V Arroyo, R García-Martinez, X Salvatella - Journal of Hepatology, 2014 - infona.pl
Human serum albumin (HSA) is one of the most frequent treatments in patients with
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …
Human serum albumin, systemic inflammation, and cirrhosis.
V Arroyo, R García-Martinez, X Salvatella - Journal of Hepatology, 2014 - europepmc.org
Human serum albumin (HSA) is one of the most frequent treatments in patients with
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …
Human serum albumin, systemic inflammation, and cirrhosis
V Arroyo, R García-Martinez… - Journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Human serum albumin (HSA) is one of the most frequent treatments in patients with
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …
[HTML][HTML] Human serum albumin, systemic inflammation, and cirrhosis
V Arroyo, R García-Martinez… - Journal of …, 2014 - journal-of-hepatology.eu
Human serum albumin (HSA) is one of the most frequent treatments in patients with
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …
[引用][C] Human serum albumin, systemic inflammation, and cirrhosis
V Arroyo, R García-Martinez… - Human serum …, 2014 - produccioncientifica.ucm.es
[PDF][PDF] Human serum albumin, systemic inflammation, and cirrhosis
V Arroyo, R García-Martinez… - Journal of …, 2014 - jvsmedicscorner.com
Human serum albumin (HSA) is one of the most frequent treatments in patients with
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …